Review of Angiogenesis-Related Gene Signature-Derived Risk Score for Glioblastoma: Prospects for Predicting Prognosis and Immune Heterogeneity in Glioblastoma

Post-publication Review of

Angiogenesis-Related Gene Signature-Derived Risk Score for Glioblastoma: Prospects for Predicting Prognosis and Immune Heterogeneity in Glioblastoma

Reviewed On June 07, 2022

Reviewed by

Actions

Content of review 1, reviewed on June 07, 2022

confidential

Source

References

Gang, W., Jin-Qu, H., Ji-Yuan, L., Xiao-Mei, Z. 2022. Angiogenesis-Related Gene Signature-Derived Risk Score for Glioblastoma: Prospects for Predicting Prognosis and Immune Heterogeneity in Glioblastoma. Frontiers in Cell and Developmental Biology.